Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Stargardt Disease

• This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease
• Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects Lesion(s) in Adolescent Subjects With STGD1
• Oral Metformin for Treatment of ABCA4 Retinopathy
• Study of STG-001 in Subjects With Stargardt Disease
• Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
• Safety and Efficacy of Emixustat in Stargardt Disease
• Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)
• Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease
• Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
• Phase 1 Safety Study of ALK-001 in Healthy Volunteers
• Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration
• Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration
• Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy
• Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy